• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早孕期超声异常且常见三体综合征游离 DNA 检测风险低的胎儿的染色体异常发生率。

Incidence of chromosomal abnormalities in fetuses with first trimester ultrasound anomalies and a low-risk cell-free DNA test for common trisomies.

机构信息

Fetal Medicine and Surgery Service, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.

Department of Clinical Science and Community Health, University of Milan, Milan, Italy.

出版信息

Prenat Diagn. 2020 Oct;40(11):1474-1481. doi: 10.1002/pd.5799. Epub 2020 Aug 9.

DOI:10.1002/pd.5799
PMID:33034897
Abstract

OBJECTIVE

To examine the incidence and type of chromosomal abnormalities in fetuses with first trimester ultrasound anomalies and a low-risk cfDNA test for common trisomies.

METHODS

In 486 singleton pregnancies undergoing invasive testing after combined screening, a detailed first trimester ultrasound assessment was carried out and a maternal blood sample was sent for cfDNA analysis. Ultrasound and cfDNA data were analyzed in relation to fetal karyotype.

RESULTS

Invasive testing demonstrated a chromosomal abnormality in 157 (32.3%) of 486 fetuses. In 348 cases with a low-risk cfDNA test for common trisomies, NT ≥ 3.5 mm and/or a major structural defect were observed in 92 (26.4%) fetuses. A chromosomal abnormality was found in 17 (18.5%; 95%CI 10.55-26.41) of these pregnancies, including 1 (1.1%) case of trisomy 21 and 16 (17.4%) fetuses with abnormalities different from common trisomies. The respective incidence in the 256 cases with a low-risk cfDNA test result and no ultrasound anomalies was 2.3% (95% CI 0.49-4.20; n = 6).

CONCLUSIONS

In fetuses with first trimester ultrasound anomalies and a low-risk cfDNA result for trisomy 21, 18 and 13, diagnostic testing should be offered with the main objective to detect chromosomal abnormalities beyond common trisomies.

摘要

目的

探讨早孕期超声异常且唐氏综合征常见三体风险 cfDNA 检测低风险的胎儿中染色体异常的发生率和类型。

方法

在 486 例接受联合筛查后进行侵袭性检测的单胎妊娠中,对所有孕妇进行详细的早孕期超声评估,并采集母体外周血进行 cfDNA 分析。对超声和 cfDNA 数据与胎儿核型进行分析。

结果

在 486 例胎儿中,157 例(32.3%)经侵袭性检测证实存在染色体异常。在 348 例唐氏综合征常见三体风险 cfDNA 检测低风险的病例中,92 例(26.4%)胎儿 NT≥3.5mm 或存在主要结构缺陷。在这些妊娠中发现 17 例(18.5%;95%CI 10.55-26.41)染色体异常,包括 1 例(1.1%)21 三体和 16 例(17.4%)不同于常见三体的异常胎儿。在 256 例 cfDNA 检测结果低风险且无超声异常的病例中,相应的发生率为 2.3%(95%CI 0.49-4.20;n=6)。

结论

对于早孕期超声异常且唐氏综合征常见三体风险 cfDNA 检测低风险的胎儿,应提供诊断性检测,主要目的是检测除常见三体以外的染色体异常。

相似文献

1
Incidence of chromosomal abnormalities in fetuses with first trimester ultrasound anomalies and a low-risk cell-free DNA test for common trisomies.早孕期超声异常且常见三体综合征游离 DNA 检测风险低的胎儿的染色体异常发生率。
Prenat Diagn. 2020 Oct;40(11):1474-1481. doi: 10.1002/pd.5799. Epub 2020 Aug 9.
2
Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency?在胎儿颈项透明层增厚的妊娠中是否应该使用游离 DNA 检测?
Ultrasound Obstet Gynecol. 2020 May;55(5):645-651. doi: 10.1002/uog.20397. Epub 2020 Apr 7.
3
Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.英国国民医疗服务体系(NHS)中胎儿三体综合征常规筛查的临床实施:基于孕早期联合检测结果的游离DNA检测
Ultrasound Obstet Gynecol. 2016 Jan;47(1):45-52. doi: 10.1002/uog.15783. Epub 2015 Oct 26.
4
First-trimester contingent screening for trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and maternal blood cell-free DNA testing.孕早期通过胎儿颈部透明带厚度、静脉导管血流及孕妇游离DNA检测对21-三体、18-三体和13-三体进行联合筛查。
Ultrasound Obstet Gynecol. 2015 Jan;45(1):42-7. doi: 10.1002/uog.14691. Epub 2014 Nov 28.
5
Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test.双胎妊娠胎儿三体的常规早孕期筛查:游离 DNA 检测取决于联合检测的结果。
Ultrasound Obstet Gynecol. 2019 Feb;53(2):208-213. doi: 10.1002/uog.20160. Epub 2018 Dec 7.
6
Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening?颈项透明层测量在不断变化的早孕期筛查模式中是否仍有作用?
Prenat Diagn. 2020 Jan;40(2):197-205. doi: 10.1002/pd.5590. Epub 2019 Nov 27.
7
[Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].孕11至13⁺⁶周几种超声软指标联合母体血清生化指标筛查胎儿染色体非整倍体的研究
Zhonghua Fu Chan Ke Za Zhi. 2013 Nov;48(11):815-8.
8
Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.在丹麦临床环境中使用游离胎儿 DNA 进行有条件的早孕期筛查非整倍体。
Ultrasound Obstet Gynecol. 2018 Apr;51(4):470-479. doi: 10.1002/uog.17562. Epub 2018 Mar 4.
9
Antenatal screening for chromosomal abnormalities.产前筛查染色体异常。
Arch Gynecol Obstet. 2022 Apr;305(4):825-835. doi: 10.1007/s00404-022-06477-5. Epub 2022 Mar 13.
10
Prospective first-trimester screening for trisomies by cell-free DNA testing of maternal blood in twin pregnancy.双胎妊娠孕妇母体外周血游离 DNA 检测行早孕期唐氏综合征筛查的前瞻性研究。
Ultrasound Obstet Gynecol. 2016 Jun;47(6):705-11. doi: 10.1002/uog.15913. Epub 2016 Apr 27.

引用本文的文献

1
Prenatal screening tests and prevalence of fetal aneuploidies in a tertiary hospital in Thailand.泰国一家三级医院的产前筛查检测与胎儿非整倍体的流行率。
PLoS One. 2023 Apr 20;18(4):e0284829. doi: 10.1371/journal.pone.0284829. eCollection 2023.
2
A Critical Evaluation of Validation and Clinical Experience Studies in Non-Invasive Prenatal Testing for Trisomies 21, 18, and 13 and Monosomy X.对21三体、18三体、13三体及X单体非侵入性产前检测的验证和临床经验研究的批判性评估
J Clin Med. 2022 Aug 15;11(16):4760. doi: 10.3390/jcm11164760.